The trading price of Plus Therapeutics Inc (NASDAQ:PSTV) closed lower on Tuesday, May 27, and closing at $0.29, -2.64% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $2.67 and a 52-week low of $0.24. Over the past month, the stock has lost -63.05% in value.
Plus Therapeutics Inc, whose market valuation is $4.95 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest PSTV has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that PSTV’s price is currently -44.24% off the SMA20 and -60.99% off the SMA50. The RSI metric on the 14-day chart is currently showing 32.90, and weekly volatility stands at 6.26%. When measured over the past 30 days, the indicator reaches 11.02%. Plus Therapeutics Inc (NASDAQ:PSTV)’s beta value is currently sitting at 0.74, while the Average True Range indicator is currently displaying 0.11.
To see how Plus Therapeutics Inc stock has been performing in comparison to its peers in the industry, here are the numbers: PSTV stock’s performance was -2.64% in the latest trading, and -86.65% in the past year.
An evaluation of the daily trading volume of Plus Therapeutics Inc (NASDAQ:PSTV) indicates that the 3-month average is 17.16 million.
Currently, records show that 17.00 million of the company’s shares remain outstanding. The insiders hold 8.87% of outstanding shares, whereas institutions hold 9.41%. However, since the stock’s price has seen -74.69% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
